Source: Annual Congress 2010 - Mast cells and eosinophils: the two key effector cells in allergic inflammation
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
F. Levy-Schaffer (Jerusalem, Israel). Mast cells and eosinophils: the two key effector cells in allergic inflammation. Annual Congress 2010 - Mast cells and eosinophils: the two key effector cells in allergic inflammation

Member's Comments

No comment yet.

Related content which might interest you: The role of mast cells in allergic inflammation: mast cells' interactions with their microenvironment Source: Annual Congress 2009 - Mast cells reborn: beyond the allergic response Year: 2009 YS4: Regulation of allergic airway disease by IL-4/IL-13 activated macrophages and dendritic cells Source: Lung Science Conference 2011 - Immune system dysregulation in chronic lung disease Year: 2011 In vivo allergen-activated inflammatory eosinophils reduced airway smooth muscle cells apoptosis in allergic asthma patients Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease Year: 2021 Distribution and degranulation of airway mast cells in normal and asthmatic subjects Source: Eur Respir J 2002; 19: 879-885 Year: 2002 γδ T cells contribute to local and systemic B cell reactivity in allergic eosinophilic airway inflammation but without a major influence on the TH1/TH2 balance Source: Eur Respir J 2002; 20: Suppl. 38, 568s Year: 2002 Dendritic cell subsets in the lung: implication for allergic asthma Source: Annual Congress 2006 - A new look at dendritic cell interactions in the lung Year: 2006 Recruitment of eosinophils and increased expression of mast cells tryptase in the bronchial mucosa of patients with allergic asthma Source: Eur Respir J 2002; 20: Suppl. 38, 508s Year: 2002 Low number of regulatory T cells in bronchial asthma: association with inflammatory cytokines Source: Annual Congress 2009 - Infections, immunity and inflammation Year: 2009 Inflammatory cell activation in eosinophilic and non-eosinophilic asthma Source: Annual Congress 2006 - Immunology of the airways Year: 2006 Interleukin-17A activation on bronchial epithelium and basophils: a novel inflammatory mechanism Source: Eur Respir J 2010; 35: 883-893 Year: 2010 Pathophysiology of asthma Source: ISSN=1025-448x, ISBN=1-904097-26-x, page=84 Year: 2003 Chymase-positive mast cells represent a major source for IL-17A in airway inflammation Source: International Congress 2015 – Mucosal immunology: what’s new in 2015 Year: 2015 Study of the effect of IL-4 and IFN-γ on Th1/Th2 cells and mast cells in allergic asthma patients Source: Eur Respir J 2001; 18: Suppl. 33, 271s Year: 2001 Chymase-positive mast cells are related to the vascular remodelling in asthma Source: Eur Respir J 2006; 28: Suppl. 50, 549s Year: 2006 T-cell co-stimulatory molecules: their role in allergic immune reactions Source: Eur Respir J 2007; 29: 1246-1255 Year: 2007